Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41
By M. Zwick, A. Labrijn, Meng Wang, C. Spenlehauer, E. Saphire, J. Binley, John P. Moore, G. Stiegler, H. Katinger, D. Burton and 1 more. Journal of Virology, 2001
876 citations recorded by the source corpus.
Subfields: Infectious Diseases, Radiology, Nuclear Medicine and Imaging, Virology
View Paper: https://www.semanticscholar.org/paper/fa68d804a860e0380209bd544d293a21c7c89cdb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
In Virology
Citations in the corpus
- Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies (2005, background): “This MAb targets an epitope (NWFDIT) located immediately downstream from the 2F5 epitope in the membrane-proximal ectodomain of gp41 (110, 125).”
- Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8 (2016, background): “10E8 belongs to a category of broadly neutralizing antibodies that includes antibodies 2F5 [9–11], 4E10 [12], and m66.”
- The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120 (2002, background): “to the C terminus of the 2F5 epitope (56, 71).”
- Generation and analyses of human synthetic antibody libraries and their application for protein microarrays. (2016, background): “However, it should be pointed out that the presence of several tryptophans in a selected binder does not necessarily imply a nonspecific binder, as exemplified by several HIV neutralizing antibodies (Zwick et al., 2001).”